Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.

Jennifer C DaviesAngela MidgleyEmil CarlssonSean DonohueIan N BruceMichael W BeresfordChristian M Hedrich

Published in: RMD open (2021)

Findings from this study show promise for clinical application of S100 proteins to predict active renal disease in SLE and response to treatment with RTX.

Keyphrases

systemic lupus erythematosus
machine learning
disease activity